Several factors have come together to help create the foundation for the biotech startup ecosystem New York City has craved for so long. Early stage life science investors, new startup incubators, and government initiatives have all played a part. And they’ve helped foster a new breed of biotechs in the city, companies with the backing to pursue cutting-edge science and the thirst to prove that life sciences startups spun out of New York research can stay, grow, and thrive in the Big Apple. Their success, or failure, will play a big part in determining the future of the ecosystem. Who are these companies, and how did they come together? Who are the people living their stories, and what challenges have they faced—and overcome—to get as far as they have?

partneringONE®: Our partnering platform through EBD Group is the most efficient way to find and meet the right people for your company’s collaborative business needs. Leverage the online system to review attendee profiles and walk into the event with pre-scheduled, one-to-one on-site meetings to accelerate partnerships and deal making! This is a great opportunity for local biotech companies to identify and meet with pharma, investors, and others in the New York region. Learn more.

3:30 – 4:15pm

Registration, Networking, & Partnering

4:15 – 4:20pm

Opening Remarks

Greg Huang – Editor in Chief, Xconomy

4:20 – 4:50pm

The HiberCell Story

How Mt. Sinai Research and Local Support Spawned an Ambitious Cancer Startup

Alan Rigby – CEO, HiberCell
Ari Nowacek – Principal, Arch Venture Partners; Co-founder, HiberCell

4:50 – 5:20pm

The Prevail Therapeutics Story

Can a Top Biotech Investor’s Parkinson’s Diagnosis Lead to a Treatment?

Emily Minkow – Chief Business Officer, Prevail Therapeutics
Asa Abeliovich – Founder & CEO, Prevail Therapeutics

5:20 – 5:50pm

The BlueRock Therapeutics Story

How Entrepreneurs and Investors Built and Sold a $1 Billion Cell Therapy Giant in NYC

Eric Soller – VP of Corporate Development & Strategy, BlueRock Therapeutics; Entrepreneur-in-residence, Versant Ventures
Shane Kovacs – Chief Business & Financial Officer, BlueRock Therapeutics
Teresa Lavoie – Principal, Fish & Richardson (moderator)

5:50 – 6:30pm

Networking Reception & Partnering

Please note this schedule is subject to change.